Gene therapy and cell transplantation for Alzheimer's disease and spinal cord injury

Yonsei Medical Journal

Volumn 45, Issue SUPPL., 2004, Pages 28-31

  Blesch, Armin ^a   Tuszynski, Mark H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Alzheimer's disease; Gene therapy; Spinal cord injury

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LENTIVIRUS VECTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; PARVOVIRUS VECTOR;

ALZHEIMER DISEASE; BONE MARROW CELL; CELL TRANSPLANTATION; CELL TYPE; DEGENERATIVE DISEASE; DNA MODIFICATION; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; GENE VECTOR; HUMAN; HYPOPHAGIA; IN VIVO STUDY; NERVE CELL; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NONHUMAN; PAIN; RAT; REVIEW; SCHWANN CELL; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; VIRAL GENE DELIVERY SYSTEM;

EID: 3543004099     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2004.45.suppl.28     Document Type: Review

References (30)

1. Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci U S A 1986;83:9231-5.
2. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 1986;6:2155-62.
3. Koliatsos VE, Nauta HJ, Clatterbuck RE, Holtzman DM, Mobley WC, Price DL. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J Neurosci 1990; 10:3801-13.
4. Tuszynski MH, Sang H, Yoshida K, Gage FH. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann Neurol 1991;30:625-36.
5. Tuszynski MH, U HS, Amaral DG, Gage FH. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci 1990;10:3604-14.
6. Dekker AJ, Winkler J, Ray J, Thal LJ, Gage FH. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience 1994;60:299-309.
7. Fischer W, Wictorin K, Bjorklund A, Williams LR, Varon S, Gage FH. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987;329:65-8.
8. Fischer W, Bjorklund A, Chen K, Gage FH. NGF improves spatial memory in aged rodents as a function of age. J Neurosci 1991;11:1889-906.
9. Winkler J, Ramirez GA, Kuhn HG, Peterson DA, Day-Lollini PA, Stewart GR, et al. Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor. Ann Neurol 1997;41:82-93.
10. Rosenberg MB, Friedmann T, Robertson RC, Tuszynski M, Wolff JA, Breakefield XO, et al. Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science 1988;242:1575-8.
11. Chen KS, Gage FH. Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration. J Neurosci 1995;15:2819-25.
12. Martinez-Serrano A, Fischer W, Bjorklund A. Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron 1995: 473-84.
13. Kordower JH, Winn SR, Liu YT, Mufson EJ, Sladek JR, Jr., Hammang JP, et al. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci U S A 1994;91:10898-902.
14. Tuszynski MH, Roberts J, Senut MC, U HS, Gage FH. Gene therapy in the adult primate brain: intra-parenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther 1996a;3:305-14.
15. Smith DE, Roberts J, Gage FH, Tuszynski MH. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc Natl Acad Sci U S A 1999;96:10893-8.
16. Conner JM, Darracq MA, Roberts J, Tuszynski MH. Non-tropic actions of neurotrophins: subcortical NGF gene delivery reverses age-related degeneration of primate cortical cholinergic innervation. Proc Natl Acad Sci U S A 2001;98:1941-6.
17. Mandel RJ, Gage FH, Clevenger DG, Spratt SK, Snyder RO, Leff SE. Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration. Exp Neurol 1999;155:59-64.
18. Blomer U, Kafri T, Randolph-Moore L, Verma IM, Gage FH. Bcl-xL protects adult septal cholinergic neurons from axotomized cell death. Proc Natl Acad Sci U S A 1998;95:2603-8.
19. Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 2003;4:703-13.
20. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004;5:146-56.
21. Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci 1997a;17:5560-72.
22. Liu Y, Kim D, Himes BT, Chow SY, Schallert T, Murray M, et al. Transplants of fibroblasts genetically modified to express brain-derived neurotrophic factor promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci 1999;19:4370-87.
23. Tuszynski MH, Thal L, U HS, Pay MM, Blesch A, Conner J, et al. Nerve growth factor gene therapy for Alzheimer's disease. J Mol Neurosci 2002;19:207.
24. Blesch A, Tuszynski MH. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transection, and induces remyelination. J Comp Neurol 2003; 467:403-17.
25. Blesch A, Uy HS, Grill RJ, Cheng JG, Patterson PH, Tuszynski MH. LIF augments corticospinal axon growth and neurotrophin expression after adult CNS injury. J Neurosci 1999;19:3556-66.
26. Lu P, Blesch A, Tuszynski MH. Neurotrophism without neurotropism: BDNF promotes survival but not growth of tesioned corticospinal neurons. J Comp Neurol 2001; 436:456-70.
27. Blesch A, Conner JM, Tuszynski MH. Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression. Gene Ther 2001;8:954-60.
28. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003;181:115-29.
29. Bunge MB, Kleitman N. Neurotrophins and neuroprotection improve axonal regeneration into Schwann cell transplants placed in transected adult rat spinal cord. In: Tuszynski MH, Kordower JH, editors. CNS Regeneration: Basic Science and Clinical Applications. San Diego: Academic Press; 1999.
30. Barnett SC, Chang L. Olfactory ensheathing cells and CNS repair: going solo or in need of a friend? Trends Neurosci 2004;27:54-60.